Barriers to Medication for Opioid Use Disorder Implementation in Jails and Postincarceration Community Settings

Bibliographic Data

ID21373267
AuthorsJessica Tveit (0009-0008-1584-6822, Univesity of Oregon, Eugene, OR, USA), Jessica Vechinski (0000-0003-4860-8317, University of Wisconsin, Madison, WI, USA, corresponding author), Neil Jacobson (0000-0002-5118-8475, University of Wisconsin, Madison, WI, USA), Faye S Taxman (0000-0001-9530-731X, George Mason University, Arlington, VA, USA), Bryce Kushmerick-Mccune (0009-0004-2444-3065, Sam Houston University, Huntsville, TX, USA), Todd Molfenter (0000-0003-3033-416X, University of Wisconsin, Madison, WI, USA)
Year2026
Volume106
Issue3
Pages317-340
Publication date2026-06-01
Open AccessYes
TypeARTICLE
VenueThe Prison Journal (JOURNAL)
Journal identifiersISSN: 0032-8855 • E-ISSN: 1552-7522
PublisherSAGE Publications (PUBLISHER • US)
DOI10.1177/00328855261431739
OpenAlexW7139969025
LanguageEN
References cited31

Embedded within a larger randomized controlled trial assessing implementation strategies for delivering medications for opioid use disorder (MOUD) in jails and during transition to community treatment, this article focuses on barriers to MOUD. Twenty-three qualitative interviews representing 19 organizations were conducted to understand these barriers. The three that surfaced as most pertinent are: policy, organizational structure, and stigma related to addiction and incarceration. This study also found a double stigma for those incarcerated and struggling with addiction, amplifying barriers to MOUD. Improving MOUD implementation is essential to reducing fatal overdoses, enhancing care postrelease, and expanding treatment access in the community

Addiction · Addiction treatment · Opiate Substitution Treatment · Opioid · Opioid use disorder · Qualitative research · Randomized controlled trial · Stigma (botany) · Substance use · HIV, Drug Use, Sexual Risk · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes